Effects of SLCO1B1 polymorphism on the pharmacokinetics of the oral antidiabetic drugs repaglinide, nateglinide, rosiglitazone, and pioglitazone

URI: http://urn.fi/URN:NBN:fi:bib:me:W00527224300
about
author
inLanguage
  • en
isPartOf
name
  • Effects of SLCO1B1 polymorphism on the pharmacokinetics of the oral antidiabetic drugs repaglinide, nateglinide, rosiglitazone, and pioglitazone
P60049

Instances

Effects of SLCO1B1 polymorphism on the pharmacokinetics of the oral antidiabetic drugs repaglinide, nateglinide, rosiglitazone, and pioglitazone

URI: http://urn.fi/URN:NBN:fi:bib:me:I00527224301
description
  • Myös verkkoaineistona ISBN 978-952-10-5040-4 (PDF)
isPartOf
name
  • Effects of SLCO1B1 polymorphism on the pharmacokinetics of the oral antidiabetic drugs repaglinide, nateglinide, rosiglitazone, and pioglitazone

Effects of SLCO1B1 polymorphism on the pharmacokinetics of the oral antidiabetic drugs repaglinide, nateglinide, rosiglitazone, and pioglitazone

URI: http://urn.fi/URN:NBN:fi:bib:me:I00565042601
description
  • Myös painettuna ISBN 978-952-92-4630-4
isPartOf
name
  • Effects of SLCO1B1 polymorphism on the pharmacokinetics of the oral antidiabetic drugs repaglinide, nateglinide, rosiglitazone, and pioglitazone
View this in Finna

Effects of SLCO1B1 polymorphism on the pharmacokinetics of the oral antidiabetic drugs repaglinide, nateglinide, rosiglitazone, and pioglitazone

URI: http://urn.fi/URN:NBN:fi:bib:me:I00527224300
datePublished
  • 2008
description
  • 5 excerpts.
  • Artikkeliväitöskirjan yhteenveto-osa ja 5 eripainosta.
  • kuvitettu
identifier
  • propertyID: FI-FENNI value: 908091
  • propertyID: FI-MELINDA value: 005272243
  • propertyID: skl value: fx908091
isbn
  • 9789529246304
isPartOf
name
  • Effects of SLCO1B1 polymorphism on the pharmacokinetics of the oral antidiabetic drugs repaglinide, nateglinide, rosiglitazone, and pioglitazone
numberOfPages
  • 81, [48] sivu
P60048
P60050
publication
  • location: Espoo organizer: Annikka Kalliokoski
publisher
  • Annikka Kalliokoski
View this in Finna

Effects of SLCO1B1 polymorphism on the pharmacokinetics of the oral antidiabetic drugs repaglinide, nateglinide, rosiglitazone, and pioglitazone

URI: http://urn.fi/URN:NBN:fi:bib:me:I00565042600
bookFormat
datePublished
  • 2008
description
  • Artikkeliväitöskirjan yhteenveto-osa.
  • Ei sisällä painetun julkaisun eripainoksia.
  • Kuvailun perusta: Nimeke nimiönäytöstä.
  • Nimeke PDF-nimiösivulta.
identifier
  • propertyID: FI-FENNI value: 908086
  • propertyID: FI-MELINDA value: 005650426
  • propertyID: skl value: fx908086
isbn
  • 9789521050404
isPartOf
name
  • Effects of SLCO1B1 polymorphism on the pharmacokinetics of the oral antidiabetic drugs repaglinide, nateglinide, rosiglitazone, and pioglitazone
numberOfPages
  • 1 PDF-tiedosto (81 s.)
P60048
P60050
publication
  • location: Helsinki organizer: Helsingin yliopisto
publisher
url

Download this resource as RDF: